FROM THE EDITOR-IN-CHIEF
The Centers for Medicare & Medicaid Services implements incentive programs to reward quality care.
by William G. Nelson, MD, PhD
A New Use for Patient Data | Measuring Treatment Effectiveness | New Option for Treating Pain From Bone Metastases | Treatment for Kids’ Brain Tumors Can Cause Hearing Problems | Helping the Helpers | What’s Next?
YOUR CANCER GUIDE
Come up with a plan to keep work projects moving forward during treatment.
by Hester Hill Schnipper
CAREGIVING WITH CONFIDENCE
A break from routine can help you be a better caregiver.
by Aimee Swartz
Project Facilitate offers assistance to medical professionals who want investigational drugs for their cancer patients.
by Richard Pazdur, MD
CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.
by Kendall K. Morgan
Some patients are benefiting from using nontraditional therapies alongside conventional treatments like surgery, chemotherapy and radiation.
by Stephen Ornes
School counselor Diane Nathaniel creates communities for herself and those around her in Brooklyn and beyond. Her cancer diagnosis led her into patient advocacy.
by Marci A. Landsmann
People with cancer and their loved ones find ways for their voices to be heard without filters.
by Bradley Jones
Nutritional Value | Stressed Out
Biochemist Samuel H. Sternberg describes the limitations, realities and potential of gene-editing technology.
Experts offer advice on feeling confident as a caregiver, adjusting to changes to day-to-day-life, and making the best use of limited energy.
Participants in Airbnb’s Open Homes program help nonprofit organizations to provide temporary lodging for cancer patients.
by Katherine Malmo
Readers share snapshots of their lives today.
Amanda Rose Ferraro’s leukemia diagnosis forced her to spend time at the hospital away from her 3-year-old-son. She calls focusing on her health and leaving her son “the hardest thing I have ever had to do.”
by Amanda Rose Ferraro
Medical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein.
by Anna Azvolinsky
Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.
by Melvin Mann
After discovering that some patients weren’t able to access the food they needed, a community oncology practice partnered with a local food bank.
by Jen Tota McGivney
Cervical cancer now accounts for less than 1% of cancer-related deaths among women in the United States.
The first new anti-cancer therapeutics approved in 2020 are for the treatment of two different types of soft tissue sarcoma.
Imaging a patient’s cancer—and the responses generated by the immune system—can provide information that may guide treatment decisions.
Follow My Lead
donate to the AACR